Irland - engelska - HPRA (Health Products Regulatory Authority)

bayer limited - gadopentetate dimeglumine - solution for injection - 0.5 mmol/ml - paramagnetic contrast media

Australien - engelska - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - gadopentetate dimeglumine, quantity: 469.01 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections; pentetate meglumine - using magnetic resonance imaging (mri) dimeglumine gadopentetate provides contrast enhancement: . in intracranial and spinal lesions in adults and children with abnormal blood-brain barrier, or abnormal vascularity; . in whole body imaging in adult patients, including the neck region, the thoracic and abdominal space, the female breast, the pelvis and the musculoskeletal system. note: reliable enhancement is not provided in imaging the pancreas and the male reproductive organs (prostate, testis and penis). indications as at 30 august 1996: using magnetic resonance imaging (mri), dimeglumine gadopentetate provides contrast enhancement; in intracranial and spinal lesions in adults and children, including neonates and infants, with an abnormal blood-brain barrier, or abnormal vascularity; in whole body imaging in adult patients, including the neck region, the thoracic and abdominal space, the female breast, the pelvis and the musculoskeletal system. note: reliable enhancement is not provided in imaging the pan

Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

schering -

Malta - engelska - Medicines Authority

bayer public limited company 400 south oak way, reading berkshire rg2 6ad, united kingdom - gadopentate dimeglumine - solution for injection - gadopentate dimeglumine - contrast media

Irland - engelska - HPRA (Health Products Regulatory Authority)

bayer limited - gadopentetate dimeglumine - solution for injection - 469 micromol - paramagnetic contrast media

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - meglumine gadopentetate - solution for injection - .002mmol/1ml

Armenien - engelska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bayer schering pharma ag - gadopentetic acid (gadopentetate dimeglumine) - solution for injection - 469mg/ml

Kanada - engelska - Health Canada

bayer inc - gadopentetate dimeglumine - solution - 469mg - gadopentetate dimeglumine 469mg - other diagnostic agents

Irland - engelska - HPRA (Health Products Regulatory Authority)

he clissmann - gadopentetate dimeglumine - oral solution - 9.38 mg/ml

Indien - engelska - Central Drugs Standard Control Organization

german r. - gadopentetic acid dimeglumine salt - v10 - 469mg(in aq. sol) - 10ml